Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Blood|September 6, 2018
Five-year follow-up of lenalidomide plus rituximab as initial treatment of mantle cell lymphomaJia Ruan, Peter Martin, Paul Christos, et al.
American Journal of Hematology|July 31, 2018
Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimensStuart E Siegel, Anjali Advani, Nita Seibel, et al.
JAMA Oncology|February 17, 2018
Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A ReviewStuart E Siegel, Wendy Stock, Rebecca H Johnson, et al.
Cancer Medicine|November 14, 2023
A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemiaAref Al-Kali, Ibrahim Aldoss, Pamela J Atherton, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2023
Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene FusionYumeng Zhang, Lynn Nguyen, Chuanyi M Lu, et al.
American Journal of Pharmaceutical Education|May 13, 2017
Point/Counterpoint: Are Outstanding Leaders Born or Made?Marjan Boerma, Elizabeth A Coyle, Michael A Dietrich, et al.
Transplantation and Cellular Therapy|April 2, 2021
Impact of Total Body Irradiation-Based Myeloablative Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-AnalysisFarhad Khimani, Mudit Dutta, Rawan Faramand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2023
Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with MyelomaCiara L Freeman, Reginald Atkins, Indumathy Varadarajan, et al.
Transplantation and Cellular Therapy|March 30, 2021
Incidence and Management of Effusions Before and After CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Large B Cell LymphomaAbu-Sayeef Mirza, Ambuj Kumar, Hamza Hashmi, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 20, 2024
Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysisJulio C Chavez, Ariel Grajales, Jose Sandoval-Sus, et al.
Pageof 13